Potential lines of attack against prostate cancer

April 17, 2018, University of East Anglia
Potential lines of attack against prostate cancer
Credit: University of East Anglia

Researchers from The University of East Anglia (UEA) have contributed to the world's largest study into genes that drive prostate cancer – identifying 80 molecular weaknesses that could be targeted by drugs to treat the disease.

The Cancer Genetics Team at Norwich Medical School, UEA, led by Prof Colin Cooper and Dr. Dan Brewer, have played an active role in this research, performing mathematical analyses, providing scientific insight and helping to lead the study.

Around a quarter of the gene mutations identified involve the targets of existing drugs that are either licensed or in clinical trials – suggesting that these could offer promise for further study as new approaches to treatment.

And the landmark research also opened up 60 new potential lines of attack against for future investigation, as well as identifying many new genes associated with the development of the .

Around 34 institutions from across the UK and internationally, analysed tumour genetics of nearly a thousand patients with prostate cancer, alongside a wealth of data.

The study is published in the journal Nature Genetics, and was largely funded by Cancer Research UK.

The researchers obtained genetic information from the tumours of 112 men with prostate cancer and pooled it with data from other studies, together analysing samples from 930 prostate cancer patients.

They combined detailed genetic analysis with the latest Big Data approaches to identify large numbers of genetic changes that underlie the development and spread of prostate cancer. They then took this genetic information and drew up a map of the network of associated proteins.

Using canSAR, a comprehensive database for cancer drug discovery, they found that 80 of the proteins in the network were possible drug targets.

Some 11 of these were targeted by existing licensed drugs and seven by drugs in clinical trials, while 62 were identified as potential targets to explore.

While further research is needed before the potential new targets could be explored in , the new study has opened up many potential ways of targeting the disease.

For example, the research raised the possibility that BRAF and ATM proteins could be targeted in prostate cancer – and research is already under way in these areas.

The team also established a timeline of genetic changes in prostate cancer, which could in future improve ways to spot the disease – as current methods of diagnosis, such as PSA testing, are unreliable.

The timeline could also help predict the way prostate cancer evolves in individual patients, which might allow treatment to be adapted to combat drug resistance.

Joint project lead, Professor Colin Cooper, Chair of Cancer Genetics at Norwich Medical School, UEA, said:

"The treatment of prostate cancer represents a significant global health problem, so it was great that experts from UEA were able to play a leading role in this pioneering research.

"The study provides an important step towards personalising treatment for men with prostate cancer. We have identified many pathways by which this cancer develops, for which new drugs can be used to disrupt those pathways and potentially improve treatment."

Study leader Professor Ros Eeles, Professor of Oncogenetics at The Institute of Cancer Research, London, said:

"Our study applied cutting-edge techniques in Big Data analysis to unlock a wealth of new information about prostate cancer and possible ways to combat the disease.

"One of the challenges we face in cancer research is the complexity of the disease and the sheer number of ways we could potentially treat it – but our study will help focus our efforts on the areas that offer most promise for patient benefit."

Study co-author Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, said:

"This study has uncovered a remarkably large number of new genes that drive the development of prostate cancer, and given us vital information about how to exploit the biology of the disease to find potential new treatments.

"We hope our findings will stimulate a wave of new research into the and potential drug targets we have identified, with the aim that patients should benefit as soon as possible."

Dr. Justine Alford from Cancer Research UK, said:

"A major hurdle to making further progress against is the lack of ways to accurately predict how a person's disease will progress, making it challenging to know which treatment is best for each patient. By greatly enhancing our understanding of the genetics behind the disease, this research edges us closer towards that goal. If confirmed by further research, in the future this knowledge could help doctors better tailor treatments to an individual's cancer, and hopefully see more people survive their disease."

Explore further: New prostate cancer risk score could help guide screening decisions

More information: Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets, Nature Genetics (2018). nature.com/articles/doi:10.1038/s41588-018-0086-z

Related Stories

New prostate cancer risk score could help guide screening decisions

January 10, 2018
A new score for predicting a man's genetic risk of developing aggressive prostate cancer could help guide decisions about who to screen and when, say researchers in The BMJ today.

Discovery of new prostate cancer biomarkers could improve precision therapy

August 14, 2017
Mayo Clinic researchers have identified a new cause of treatment resistance in prostate cancer. Their discovery also suggests ways to improve prostate cancer therapy. The findings appear in Nature Medicine. In the publication, ...

Marker for aggressive prostate cancer doubles up as a drug target

November 8, 2016
Researchers have discovered that a marker found on aggressive prostate cancer cells could also be used as a way to guide treatments to the cancer, according to new research presented at the National Cancer Research Institute ...

Research breakthrough could lead to better prostate cancer treatment

November 19, 2015
Cancer researchers from the University of Glasgow and Royal Philips Cancer researchers have identified a gene which could help doctors to predict the aggressiveness of prostate cancer in patients.

New imaging approach fast tracks drug testing for incurable prostate cancer

March 17, 2014
Cancer Research UK-funded scientists have developed a new way to test the effectiveness of a drug for prostate cancer that has spread to the bone, which is currently incurable, according to research published in the Journal ...

Mutation in prostate tumors shown to change epigenetic identity, the make-up of DNA

August 7, 2017
Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make-up of DNA, in about 50% of patient tumour samples. The discovery also identifies a new opportunity for ...

Recommended for you

Daily low-dose aspirin may be weapon against ovarian cancer

July 20, 2018
(HealthDay)— One low-dose aspirin a day could help women avoid ovarian cancer or boost their survival should it develop, two new studies suggest.

Discovery of kidney cancer driver could lead to new treatment strategy

July 19, 2018
University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change ...

High fruit and vegetable consumption may reduce risk of breast cancer, especially aggressive tumors

July 19, 2018
Women who eat a high amount of fruits and vegetables each day may have a lower risk of breast cancer, especially of aggressive tumors, than those who eat fewer fruits and vegetables, according to a new study led by researchers ...

Sunscreen reduces melanoma risk by 40 per cent in young people

July 19, 2018
A world-first study led by University of Sydney has found that Australians aged 18-40 years who were regular users of sunscreen in childhood reduced their risk of developing melanoma by 40 percent, compared to those who rarely ...

Analysis of prostate tumors reveals clues to cancer's aggressiveness

July 19, 2018
Using genetic sequencing, scientists have revealed the complete DNA makeup of more than 100 aggressive prostate tumors, pinpointing important genetic errors these deadly tumors have in common. The study lays the foundation ...

Complementary medicine for cancer can decrease survival

July 19, 2018
People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.